Anthony Hayes A Ikido Pharma Inc. (AIKI) insider trading activity

AIKI Quotes by TradingView

Anthony Hayes is CEO of AIkido Pharma Inc.. Currently has a direct ownership of 377,705 shares of AIKI, which is worth approximately $1.44 Million. The most recent transaction as insider was on Jun 11, 2024, when has been sold 154,559 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 378K
0% 3M change
72.86% 12M change
Total Value Held $1.44 Million

Anthony Hayes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Grant, award, or other acquisition
-
154,559 Added 29.04%
377,705 Common Stock
May 30 2024
BUY
Open market or private purchase
$8,356 $2.4 p/Share
3,482 Added 1.54%
223,146 Common Stock
May 29 2024
BUY
Open market or private purchase
$2,605 $2.25 p/Share
1,158 Added 0.52%
219,664 Common Stock
Aug 23 2023
BUY
Open market or private purchase
$5,720 $2.86 p/Share
2,000 Added 0.91%
218,506 Common Stock
Aug 16 2023
BUY
Open market or private purchase
$5,880 $2.94 p/Share
2,000 Added 0.92%
216,506 Common Stock
Jun 14 2023
BUY
Open market or private purchase
$3,785 $2.87 p/Share
1,319 Added 0.61%
214,506 Common Stock
Jun 13 2023
BUY
Open market or private purchase
$1,462 $2.89 p/Share
506 Added 0.24%
213,187 Common Stock
May 24 2023
BUY
Open market or private purchase
$5,500 $2.75 p/Share
2,000 Added 0.93%
212,681 Common Stock
May 17 2023
BUY
Open market or private purchase
$5,540 $2.77 p/Share
2,000 Added 0.94%
210,681 Common Stock
May 16 2023
BUY
Open market or private purchase
$5,540 $2.77 p/Share
2,000 Added 0.95%
208,681 Common Stock
Apr 04 2023
BUY
Open market or private purchase
$103,200 $3.44 p/Share
30,000 Added 12.68%
206,681 Common Stock
Dec 14 2022
BUY
Open market or private purchase
$16,605 $3.69 p/Share
4,500 Added 2.48%
176,681 Common Stock
Dec 13 2022
BUY
Open market or private purchase
$18,500 $3.7 p/Share
5,000 Added 2.82%
172,181 Common Stock
Dec 12 2022
BUY
Open market or private purchase
$18,100 $3.62 p/Share
5,000 Added 2.9%
167,181 Common Stock
Dec 09 2022
BUY
Open market or private purchase
$18,400 $3.68 p/Share
5,000 Added 2.99%
162,181 Common Stock
Dec 08 2022
BUY
Open market or private purchase
$17,800 $3.56 p/Share
5,000 Added 3.08%
157,181 Common Stock
Dec 07 2022
BUY
Open market or private purchase
$17,400 $3.48 p/Share
5,000 Added 3.18%
152,181 Common Stock
Sep 13 2022
BUY
Open market or private purchase
$157,728 $6.32 p/Share
24,957 Added 14.5%
147,181 Common Stock
Sep 12 2022
BUY
Open market or private purchase
$241,857 $6.33 p/Share
38,208 Added 23.82%
122,224 Common Stock
Aug 26 2022
BUY
Grant, award, or other acquisition
$471,528 $6.0 p/Share
78,588 Added 48.33%
84,016 Common Stock
May 03 2021
BUY
Open market or private purchase
$9,900 $0.99 p/Share
10,000 Added 11.31%
78,430 Common Stock
Apr 29 2021
BUY
Open market or private purchase
$9,900 $0.99 p/Share
10,000 Added 12.75%
68,430 Common Stock
Apr 22 2021
BUY
Open market or private purchase
$9,300 $0.93 p/Share
10,000 Added 14.61%
58,430 Common Stock
AH

Anthony Hayes

CEO
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIKI